A SpaceX Stock Split Could Be Closer Than Investors Think

The article argues a SpaceX stock split is unlikely soon: its shares are below $162, while its current price-to-sales ratio is 103 and the author sees valuation compression as a risk. A hypothetical SpaceX-Tesla merger would combine forecast 2026 revenue of $152 billion and a market cap of about $3.7 trillion, implying a forward P/S ratio of 24; a split scenario would require the combined multiple to rise to 107, or roughly $1,260 per share. The merger is speculation, not a reported deal, and the article advises investors not to expect a split in the near term.

Analysis

The key mispricing risk is treating a stock split as evidence of value creation. A split changes neither enterprise value nor the revenue multiple; the article’s hypothetical per-share outcomes are especially fragile because they depend on an assumed merger structure, exchange ratio, and diluted share count. A SpaceX–Tesla combination could instead widen the valuation discount if investors view it as adding governance, capital-allocation, and regulatory complexity. For Tesla holders, the relevant question is not the headline combined sales multiple but whether any transaction transfers value to them or uses their equity to finance assets they do not want.

Over days to weeks, merger or split chatter could support SPCX sentiment, but the signal is weak without credible filings or transaction details. Over 1–3 months, watch for verified revenue quality and guidance: a large sales base alone does not establish margins, cash generation, or a path to justify a premium multiple. Over 6–18 months, sustained revenue growth could help defend valuation, while multiple compression remains the larger downside if growth disappoints or the market reprices long-duration equities. NVDA’s historical multiple compression is a cautionary analogy, not a forecast for SPCX.

The contrarian point: the split narrative may distract from the more consequential issue—whether the implied valuation can survive ordinary execution risk. No trade should be based on the article’s merger arithmetic alone; verify current filings, share counts, float/borrow and deal evidence first.

Key Decisions for Investors

• Do not buy SPCX solely on split speculation. A split is mechanically neutral, and the article’s per-share scenario is not an estimate of merger value.
• Treat SPCX as a watch rather than an outright short until borrow availability, liquidity, current valuation inputs, and revenue quality are verified. If credible merger chatter produces a sharp sentiment-driven rally without supporting filings, consider a defined-risk put spread rather than an unbounded short.
• For TSLA, monitor any formal transaction terms for dilution, exchange ratio, governance and capital commitments; a combination could create a conglomerate discount even if reported sales scale rises.
• Falsifiers for a bearish valuation view: independently verified, sustained revenue growth accompanied by improving cash generation or a materially lower valuation multiple without a corresponding share-price decline. Reassess if filings or guidance establish a credible transaction and its economics.